Sudan (the)

in page functions
[French]
Sudan
Total population (2016) 41,175,337
Birth cohort (2016) 1,333,199
Surviving Infants (surviving to 1 year per year, 2016) 1,266,925
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 48/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 70/1000
World Bank Index, IDA (2012) 2.44
Co-financing status (2016) Preparatory transition
No. of districts/territories (2015) 184

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Sudan

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $351,703,034 $399,501,954 $323,724,852
Health system strengthening (HSS 1) $16,153,500 $16,153,500 $16,153,500 100%
Health system strengthening (HSS 2) $23,742,846 $36,399,766 $9,885,620 42%
HepB mono (NVS) $3,027,132 $3,027,132 $3,027,132 100%
Immunisation services support (ISS) $11,229,380 $11,229,380 $11,229,378 100%
Injection Safety Devices (NVS) $556,500 $556,500
Injection safety support (INS) $1,321,257 $1,321,257 $1,321,257 100%
IPV (NVS) $3,505,649 $3,505,649 $2,283,327 65%
Meningitis A (NVS) $2,051,000 $2,051,000 $603,097 29%
Meningitis A - campaign (NVS) $16,988,586 $16,988,586 $16,988,586 100%
Meningitis A - mini catch-up campaign (NVS) $3,343,500 $3,343,500 $3,229,188 97%
Meningitis A - mini catch-up op.costs (OPC) $2,660,854 $2,660,854 $2,660,854 100%
Meningitis A - operational costs (OPC) $16,135,366 $16,135,366 $16,135,366 100%
Penta (NVS) $95,368,215 $95,368,215 $91,913,882 96%
Pneumo (NVS) $91,328,241 $91,328,241 $84,561,772 93%
Rotavirus (NVS) $35,639,888 $35,639,888 $35,080,775 98%
Vaccine Introduction Grant (VIG) $3,917,159 $3,917,159 $3,917,159 100%
Yellow Fever - campaign (NVS) $16,796,659 $40,901,159 $16,796,659 100%
YF - Operational costs (OPC) $7,937,302 $18,974,802 $7,937,302 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Sudan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 93%
M:F sex ratio at birth (2016) 1.04
Household survey: DTP3 coverage for male (2005) 53.70%
Household survey: DTP3 coverage for female (2005) 55.90%
Household survey: Last DTP3 survey (2009) 59%
% districts achieving > 80% DTP3 coverage (2015) 83%
% districts achieving < 50% DTP3 coverage (2015) 2%
MCV WHO/UNICEF estimates (2015) 87%

Breakdown of support

Non-vaccine support Vaccine support
21% 79%
$69,240,436 $254,484,410

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Sudan

10 November 2016

Tanzania

Measles jab saves over 20 million young lives in 15 years, but hundreds of children still die of the disease every day

Measles outbreaks in numerous countries – caused by gaps in routine immunisation and in mass vaccination campaigns – continue to be a serious challenge.

19 October 2016

A baby is immunised with pentavalent vaccine in South Sudan..jpg

Millions more children to be protected from five diseases thanks to new vaccine supply agreement

5-in-1 pentavalent vaccine will come from a broad base of manufacturers at half the 2016 average price for the next three years.

19 September 2016

Stockpiling

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

close icon

modal window here